JP2023519261A5 - - Google Patents
Info
- Publication number
- JP2023519261A5 JP2023519261A5 JP2022557789A JP2022557789A JP2023519261A5 JP 2023519261 A5 JP2023519261 A5 JP 2023519261A5 JP 2022557789 A JP2022557789 A JP 2022557789A JP 2022557789 A JP2022557789 A JP 2022557789A JP 2023519261 A5 JP2023519261 A5 JP 2023519261A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- antibody
- cancer
- pharmaceutically acceptable
- drug conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010218297 | 2020-03-25 | ||
| CN202010218297.4 | 2020-03-25 | ||
| PCT/CN2021/082857 WO2021190583A1 (zh) | 2020-03-25 | 2021-03-25 | 抗psma抗体-依喜替康类似物偶联物及其医药用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023519261A JP2023519261A (ja) | 2023-05-10 |
| JP2023519261A5 true JP2023519261A5 (https=) | 2024-04-02 |
Family
ID=77890968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557789A Pending JP2023519261A (ja) | 2020-03-25 | 2021-03-25 | 抗ｐｓｍａ抗体－エキサテカン類似体複合体及びその医薬用途 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230140397A1 (https=) |
| EP (1) | EP4130006A4 (https=) |
| JP (1) | JP2023519261A (https=) |
| KR (1) | KR20220160016A (https=) |
| CN (1) | CN115298186B (https=) |
| AU (1) | AU2021240756A1 (https=) |
| BR (1) | BR112022019027A2 (https=) |
| CA (1) | CA3177279A1 (https=) |
| MX (1) | MX2022011808A (https=) |
| TW (1) | TWI888517B (https=) |
| WO (1) | WO2021190583A1 (https=) |
| ZA (1) | ZA202210724B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023083381A1 (zh) | 2021-11-15 | 2023-05-19 | 成都百利多特生物药业有限责任公司 | 双特异性抗体-喜树碱类药物偶联物及其医药用途 |
| US11814394B2 (en) | 2021-11-16 | 2023-11-14 | Genequantum Healthcare (Suzhou) Co., Ltd. | Exatecan derivatives, linker-payloads, and conjugates and thereof |
| IL318296A (en) | 2022-07-15 | 2025-03-01 | Genequantum Healthcare Suzhou Co Ltd | Anti-TROP2 antibody and its conjugate |
| CN121487754A (zh) * | 2023-07-25 | 2026-02-06 | 江苏恒瑞医药股份有限公司 | 靶向c-Met的抗体-药物偶联物及其医药用途 |
| AU2024319528A1 (en) * | 2023-08-04 | 2026-02-12 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Anti-psma antibody-drug conjugate and pharmaceutical use thereof |
| WO2025145034A1 (en) * | 2023-12-29 | 2025-07-03 | T.O.A.D. Oncology Sa | Anti-psma conjugates and methods of using the same |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US6504029B1 (en) | 1995-04-10 | 2003-01-07 | Daiichi Pharmaceutical Co., Ltd. | Condensed-hexacyclic compounds and a process therefor |
| WO2003000657A1 (en) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| JP5355839B2 (ja) | 2001-10-23 | 2013-11-27 | ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． | Ｐｓｍａ抗体およびタンパク質マルチマー |
| EP2478912B1 (en) | 2003-11-06 | 2016-08-31 | Seattle Genetics, Inc. | Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy |
| DK1912677T3 (da) * | 2005-06-20 | 2014-01-13 | Psma Dev Company L L C | PSMA-antistof-lægemiddel-konjugater |
| US20160095939A1 (en) * | 2014-10-07 | 2016-04-07 | Immunomedics, Inc. | Neoadjuvant use of antibody-drug conjugates |
| CA2859965A1 (en) | 2011-12-21 | 2013-06-27 | Ardelyx, Inc. | Non-systemic tgr5 agonists |
| EP2802325B1 (en) | 2012-01-13 | 2016-11-30 | The General Hospital Corporation | Anesthetic compounds and related methods of use |
| ES2773710T3 (es) * | 2012-10-11 | 2020-07-14 | Daiichi Sankyo Co Ltd | Enlazadores para conjugados de anticuerpo - fármaco |
| WO2015012904A2 (en) * | 2012-12-13 | 2015-01-29 | Immunomedics, Inc. | Antibody-sn-38 immunoconjugates with a cl2a linker |
| IL310627B2 (en) | 2014-01-31 | 2026-04-01 | Daiichi Sankyo Co Ltd | Anti-HER2 antibody-drug conjugates, compositions containing them and uses thereof |
| EP3130608B1 (en) * | 2014-04-10 | 2019-09-04 | Daiichi Sankyo Co., Ltd. | (anti-her2 antibody)-drug conjugate |
| US10195175B2 (en) * | 2015-06-25 | 2019-02-05 | Immunomedics, Inc. | Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors |
| WO2017046746A1 (en) * | 2015-09-15 | 2017-03-23 | Acerta Pharma B.V. | Therapeutic combinations of a btk inhibitor and a gitr binding molecule, a 4-1bb agonist, or an ox40 agonist |
| EP3464379B1 (en) * | 2016-06-06 | 2023-09-27 | Abzena (UK) Limited | Antibodies, uses thereof and conjugates thereof |
| US11993661B2 (en) * | 2018-06-18 | 2024-05-28 | Eureka Therapeutics, Inc. | Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof |
| WO2020063676A1 (zh) * | 2018-09-26 | 2020-04-02 | 江苏恒瑞医药股份有限公司 | 依喜替康类似物的配体-药物偶联物及其制备方法和应用 |
| CN112125915A (zh) * | 2019-09-18 | 2020-12-25 | 四川百利药业有限责任公司 | 一种喜树碱衍生物及其偶联物 |
-
2021
- 2021-03-25 MX MX2022011808A patent/MX2022011808A/es unknown
- 2021-03-25 WO PCT/CN2021/082857 patent/WO2021190583A1/zh not_active Ceased
- 2021-03-25 BR BR112022019027A patent/BR112022019027A2/pt unknown
- 2021-03-25 US US17/914,209 patent/US20230140397A1/en active Pending
- 2021-03-25 JP JP2022557789A patent/JP2023519261A/ja active Pending
- 2021-03-25 CA CA3177279A patent/CA3177279A1/en active Pending
- 2021-03-25 TW TW110110881A patent/TWI888517B/zh active
- 2021-03-25 AU AU2021240756A patent/AU2021240756A1/en active Pending
- 2021-03-25 CN CN202180022490.3A patent/CN115298186B/zh active Active
- 2021-03-25 KR KR1020227035634A patent/KR20220160016A/ko active Pending
- 2021-03-25 EP EP21775717.8A patent/EP4130006A4/en active Pending
-
2022
- 2022-09-28 ZA ZA2022/10724A patent/ZA202210724B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510905A5 (https=) | ||
| JP2023519261A5 (https=) | ||
| JP2023505708A5 (https=) | ||
| JP2022511351A5 (https=) | ||
| CA2933666C (en) | Anti-trop2 antibody-drug conjugate | |
| CN107148285B (zh) | 吡咯并苯并二氮杂䓬-抗体缀合物 | |
| TWI891749B (zh) | 抗體-藥物偶聯物及其醫藥用途 | |
| AU2025201016A1 (en) | Therapy for drug-resistant cancer by administration of anti-HER2 antibody/drug conjugate | |
| JP2023506805A5 (https=) | ||
| WO2015146132A1 (ja) | 抗ｃｄ９８抗体－薬物コンジュゲート | |
| JP2017534253A5 (https=) | ||
| RU2014113304A (ru) | Анти-cd40-антитела, применение и методы | |
| JP2015523380A5 (https=) | ||
| TW202537975A (zh) | 抗體－藥物結合物之製造方法 | |
| TW202227501A (zh) | 抗ｇａｒｐ抗體及其製造方法及用途 | |
| CN116096896A (zh) | 一种含抗体药物偶联物的药物组合物及其用途 | |
| JP2020504112A5 (https=) | ||
| AU2018328015A1 (en) | Compounds for reducing the viscosity of biological formulations | |
| CA3243873A1 (en) | Immune Antigen-Specific IL-18 Immune Cytokines and Their Uses | |
| JP2025503493A5 (https=) | ||
| JP2024523422A5 (https=) | ||
| NL2020121B1 (en) | Platinum-based functional moieties for preparing cell targeting conjugates | |
| JP2024536798A5 (https=) | ||
| RU2022125170A (ru) | Конъюгат антитела против PSMA и аналога эксатекана и его медицинское применение | |
| TH2101001650A (th) | ลิแกนด์-ดรักคอนจูเกตของสารแอนะล็อกของเอกซาทีแคน, วิธีการเตรียมสำหรับคอนจูเกตนั้น และการประยุกต์ใช้คอนจูเกตดังกล่าว |